Browsing Over 156 Presentations

Sort By

Panel discussion and Live Q&A

PSMA-targeted therapy: new horizons in mCRCP

DLL3-targeted agents in small-cell lung cancer

Treating unresectable Stage III NSCLC with immuno-oncology: A clinical case study

Live panel discussion and audience Q&A

Meeting close

Welcome and introduction

The role of immuno-oncology combinations in ES-SCLC: A clinical case study

At the cutting edge of cancer immunotherapy – in collaboration with SITC Special session

Q&A and live discussion

Lecture Time
13:35 - 13:51
Speakers
  • All Speakers (, Switzerland)
Session Name
At the cutting edge of cancer immunotherapy – in collaboration with SITC
Channel
Channel 3
Date
12.12.2020
Time
12:35 - 13:55
Authors
  • All Speakers (, Switzerland)
At the cutting edge of cancer immunotherapy – in collaboration with SITC Special session

Anti-angiogenic compounds improve immunotherapy outcomes

Lecture Time
12:35 - 12:50
Speakers
  • Arjan Griffioen (Amsterdam, Netherlands)
Session Name
At the cutting edge of cancer immunotherapy – in collaboration with SITC
Channel
Channel 3
Date
12.12.2020
Time
12:35 - 13:55
Authors
  • Arjan Griffioen (Amsterdam, Netherlands)
At the cutting edge of cancer immunotherapy – in collaboration with SITC Special session

Microbiomes in tumor Immunobiology and immune therapies

Lecture Time
12:50 - 13:05
Speakers
  • Arielle Elkrief (Montreal, QC, Canada)
Session Name
At the cutting edge of cancer immunotherapy – in collaboration with SITC
Channel
Channel 3
Date
12.12.2020
Time
12:35 - 13:55
Authors
  • Arielle Elkrief (Montreal, QC, Canada)
At the cutting edge of cancer immunotherapy – in collaboration with SITC Special session

Regulatory T cells: Biology and targeting

Lecture Time
13:05 - 13:20
Speakers
  • Hiroyoshi Nishikawa (Tokyo, Japan)
Session Name
At the cutting edge of cancer immunotherapy – in collaboration with SITC
Channel
Channel 3
Date
12.12.2020
Time
12:35 - 13:55
Authors
  • Hiroyoshi Nishikawa (Tokyo, Japan)